MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2019 International Congress

    Computerized cognitive test profile of 100 patients with and without Amyloid beta 1-42 burden

    F. Waga, I. Liepelt-Scarfone, M. Bentele, W. Maetzler, S. Becker, M. Timmers, L. van Nueten, G. Salvadore, K. Brockmann, M. Hobert, J. Streffer, D. Berg (Titusville, NJ, USA)

    Objective: To investigate whether a computerized neuropsychological assessment can detect subtle cognitive impairment associated with Aβ pathology in Parkinson’s disease (PD). Background: Parenchymal Aβ pathology…
  • 2019 International Congress

    Specific SLC6A3 variant shows association with better memory in PD patients longitudinally

    M. Ramezani, K. Martens, JS. Provost, I. Kathol, Z. Javer, J. Cheetham, E. Yoon, M. Kibreab, T. Hammer, ST. Lang, T. Alrazi, A. Robichaud, JR. Sarna, D. Martino, G. Pfeffer, O. Monchi (Calgary, AB, Canada)

    Objective: To study the effect of SLC6A3VNTR on PD patients’ cognition longitudinally. Background: Solute carrier family 6 neurotransmitter transporter dopamine member 3gene (SLC6A3) has two common…
  • 2019 International Congress

    Relationship between eye movements during natural reading and basic oculomotor tasks in PD

    J. Waldthaler, L. Stock, C. Krüger-Zechlin, L. Timmermann (Marburg, Germany)

    Objective: To investigate the relationship of eye movement characteristics during natural, self-paced reading and basic visually-guided saccades (VGS) and antisaccades (AS) tasks in PD. Background:…
  • 2019 International Congress

    Tracking cortical changes throughout cognitive decline in Parkinson’s disease: a longitudinal MRI study

    E. Canu, F. Agosta, T. Stojković, S.. Basaia, I. Stankovic, V. Markovic, I. Petrović, E. Stefanova, V. Kostic, M. Filippi (Milan, Italy)

    Objective: To investigate longitudinal cortical thinning (CT) in Parkinson’s disease (PD) patients with normal cognition (PD-CN), stable mild cognitive impairment (PD-MCIs), and patients who convert…
  • 2019 International Congress

    Pre-frontal activation during walking in Parkinson’s disease: the impact of attention

    S. Stuart, A. Giritharan, J. Quinn, M. Mancini (Portland, OR, USA)

    Objective: This study aimed to; 1) examine pre-frontal cortex (PFC) activation during walking in response to increased attentional load (dual-task) in Parkinson’s disease (PD); and…
  • 2019 International Congress

    The efficiency of group cognitive rehabilitation to patients with Parkinson’s disease in comparison to relaxation therapy: pilot data

    V. Plzáková, D. Enström, T. Nikolai (Prague, Czech Republic)

    Objective: The aim of this study was to compare the efficiency of group cognitive rehabilitation to patients with Parkinson´s disease (PD) in comparison to group…
  • 2019 International Congress

    Neuropsychiatric clusters in patients with Parkinson’s disease and their clinical and demographic correlates

    M. Sommerauer, C. Schedlich-Teufer, P. Reker, E. Kalbe, J. Kessler, M. Barbe (Köln, Germany)

    Objective: To assess clusters of neuropsychiatric symptoms in Parkinson’s disease and their relation to motor symptoms and demographic markers in a large PD cohort. Background:…
  • 2019 International Congress

    Scene Induced emotion processing in Parkinson’s disease: BOLD-fMRI study

    S. Boujraf, M. Benzagmout, B. Alami, H. Amadou, H. El Hamdaoui, A. Bennani, M. Jaafari, I. Rammouz, M. Maaroufi, D. Boussaoud (Fez, Morocco)

    Objective: The aim of this study was to investigate emotional processing organization in the brain of patients with Parkinson's disease and to explore whether there…
  • 2019 International Congress

    The contribution of cerebrovascular risk factors, metabolic and inflammatory changes to cognitive decline in Parkinson’s disease

    I. Rektor, B. Vesely, N. Bohnen, E. Koritakova, E. Kurca, P. Valkovic (Brno, Czech Republic)

    Objective: To examine the contributions of systemic factors to clinically relevant cognitive decline in Parkinson’s disease (PD), we studied the impact of cardiometabolic and inflammatory…
  • 2019 International Congress

    Smell and taste in cervical dystonia: a contribution to understand dystonia pathophysiology.

    T. Herr, T. Hummel, M. Vollmer, C. Willert, B. Lehnert, M. Kronenbürger (Greifswald, Germany)

    Objective: To contribute to the better understanding of the pathophysiology of cervical dystonia (CD) we systematically assessed olfactory and gustatory functioning in CD subjects and…
  • « Previous Page
  • 1
  • …
  • 71
  • 72
  • 73
  • 74
  • 75
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley